CoChat
Sign Up
Cited by 153COVID-19 Clinical Research StudiesChronic Obstructive Pulmonary Disease (COPD) ResearchLong-Term Effects of COVID-19

Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID‐19)

Open access
Yang, Lu‐Lu, Yang, Ting·2020·Chronic Diseases and Translational Medicine
DOI 10.1016/j.cdtm.2020.05.002PMC PMC7221406
Open this paper in CoChat — free accountOpen PDF

Abstract

As a highly infectious respiratory tract disease, coronavirus disease 2019 (COVID‐19) can cause respiratory, physical, and psychological dysfunction in patients. Therefore, pulmonary rehabilitation is crucial for both admitted and discharged patients of COVID‐19. In this study, based on the newly released pulmonary rehabilitation guidelines for patients with COVID‐19, as well as evidence from the pulmonary rehabilitation of patients with severe acute respiratory syndrome, we investigated pulmonary rehabilitation for patients with COVID‐19 having complications, such as chronic pulmonary disease, and established an intelligent respiratory rehabilitation model for these patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cdtm.2020.05.002

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Severe respiratory symptoms can cause respiratory failure (ARDS), which can lead to death unless promptly managed using ventilation at ICU.

    “As mentioned before, severe respiratory symptoms can cause respiratory failure (ARDS), which can lead to death unless promptly managed using ventilation at ICU [2, 3, 6].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [6]

    The section ‘Necessity of pulmonary rehabilitation for patients with COVID-19’ says severe cases can rapidly progress to ARDS. The ‘Pulmonary rehabilitation guidelines’ section says life-saving measures should take priority for unstable severe or critical cases, but our copy does not say that ARDS leads to death unless promptly treated with ventilation in an ICU. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

  • Respiratory rehabilitation is crucial for the recovery of patients with viral pneumonia from COVID-19 during the acute and rehabilitation phases.

    “Respiratory rehabilitation is crucial for the recovery of patients with viral pneumonia from COVID-19 during the acute and rehabilitation phases [6, 9].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [6]

  • Respiratory rehabilitation should be considered when there are no signs of progressive deterioration and patients are hospitalised, as recommended by Chinese, the Netherlands, Italian, and UK rehabilitation professionals [6, 10, 15, 17, 33].

    “Respiratory rehabilitation should be considered when there are no signs of progressive deterioration and patients are hospitalised, as recommendations by Chinese, the Netherlands, Italian, and UK rehabilitation professionals [6, 10, 15, 17, 33].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [6]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 20

  1. [3]Pauwels R.A. Buist A.S. Calverley P.M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2001 1256 1276 11316667
  2. [5]COPD Working Group Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis Ont Health Technol Assess Ser 12 2012 1 75 PMC3384375 23074434
  3. [6]Charususin N. Gosselink R. Decramer M. Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD Thorax 73 2018 942 950 29914940
  4. [8]Calik-Kutukcu E. Arikan H. Saglam M. Arm strength training improves activities of daily living and occupational performance in patients with COPD Clin Res J 11 2017 820 832 26621050
  5. [9]Tarigan A.P. Pandia P. Mutiara E. Pradana A. Rhinsilva E. Efriyandi E. Impact of lower-limb endurance training on dyspnea and lung functions in patients with COPD Open Access Maced J Med Sci 6 2018 2354 2358 30607190 PMC6311482
  6. [11]Khalid M. Al Rabiah F. Khan B. Al Mobeireek A. Butt T.S. Al Mutairy E. Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases Antivir Ther 20 2015 87 91 24831606
  7. [13]Hong D.S. Wang R.R. Ye Z.Q. Rao Y.F. Xu K.J. Lu X.Y. The effect of interferon combined with ribavirin on the risk of death in patients with Severe Coronavirus Infection: a Systematic Review based on previous MERS-CoV studies (in Chinese) Chin J Hosp Pharm 2020 1 7
  8. [14]Wang M. Cao R. Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Cell Res 30 2020 269 271 32020029 PMC7054408
  9. [15]Chen T. Chen G. Guo W. A quick guidelinefor novel coronavirus pneumonia (Trial 3rd Edition) (in Chinese) Herald Med 39 2020 305 307
  10. [16]Jiang F. Deng L. Zhang L. Cai Y. Cheung C.W. Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) J Gen Intern Med 35 2020 1545 1549 32133578 PMC7088708
  11. [17]Huang C. Wang Y. Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 2020 497 506 31986264 PMC7159299
  12. [18]Tian S. Hu W. Niu L. Liu H. Xu H. Xiao S.Y. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer J Thorac Oncol 15 2020 700 704 32114094 PMC7128866
  13. [21]Hui D.S. Joynt G.M. Wong K.T. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors Thorax 60 2005 401 409 15860716 PMC1758905
  14. [22]Ng C.K. Chan J.W. Kwan T.L. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors Thorax 59 2004 889 891 15454656 PMC1746851
  15. [23]Lee N. Hui D. Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 2003 1986 1994 12682352
  16. [25]Lau H.M. Ng G.Y. Jones A.Y. Lee E.W. Siu E.H. Hui D.S. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome Aust J Physiother 51 2005 213 219 16321128 PMC7130114
  17. [29]Nonoyama M.L. Brooks D. Lacasse Y. Guyatt G.H. Goldstein R.S. Oxygen therapy during exercise training in chronic obstructive pulmonary disease Cochrane Database Syst Rev 2007 CD005372 17443585 PMC8885311
  18. [30]Henderson R.C. Specter B.B. Kyphosis and fractures in children and young adults with cystic fibrosis J Pediatr 125 1994 208 212 8040763
  19. [31]Rassouli F. Boutellier D. Duss J. Huber S. Brutsche M.H. Digitalizing multidisciplinary pulmonary rehabilitation in COPD with a smartphone application: an international observational pilot study Int J Chronic Obstr Pulm Dis 13 2018 3831 3836 PMC6260122 30538444
  20. [32]Bourne S. DeVos R. North M. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial BMJ Open 7 2017 e014580 PMC5541506 28716786

Cited by

Sorted by citations

Authors
Yang, L., & Yang, T.
Affiliations
  • Capital Medical University (CN)
  • China-Japan Friendship Hospital (CN)
Corresponding author
Yang, Ting
ORCID
Yang, Ting
Venue
Chronic Diseases and Translational Medicine
Publisher
Wiley
Published
2020-06
Volume
6
Issue
2
Pages
79-86
ISSN
  • 2095-882X (ISSN-L)
  • 2589-0514
DOI
10.1016/j.cdtm.2020.05.002
PMC
PMC7221406
OpenAlex
W3025379909
Cited by
153
References
5
Citations by year
2026: 2 · 2025: 7 · 2024: 13 · 2023: 26 · 2022: 38 · 2021: 43 · 2020: 24
FWCI
1.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Chronic Diseases and Translational Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Chinese Academy of Medical Sciences, Research on Prevention and Control System of Chronic Airway Diseases (2019TX320005)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
pulmonary rehabilitation, COVID-19 pandemic, chronic lung disease, SARS, rehabilitation guidelines, respiratory dysfunction, psychological dysfunction, discharged patients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review